FDA Clears Roche’s Cobas c 703 and ISE Neo Analytical Units
The FDA has cleared Roche’s cobas c 703 and cobas ISE neo, high-throughput analytical units designed to automate workflows and address staffing and capacity challenges.
Latest Articles
Editor's Top Picks
Ordering Both ESR and CRP Tests Could Save Hospitals Nearly $10 Million Per Year, Study Finds
A peer-reviewed economic analysis challenges the assumption that erythrocyte sedimentation rate and C-reactive protein tests are interchangeable, finding that combined testing reduces misdiagnoses and lowers overall costs.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
AI-Powered Virtual Staining Now Available as On-Premises Hardware for Pathology Labs
Pictor Labs has introduced an on-premises hardware system for AI-powered virtual staining, enabling pathology labs to generate digital stains locally without transferring tissue images to external cloud infrastructure.
Equipment & Supply Spotlight
12 Life Science Startups Named to SLAS Europe 2026 Innovation Showcase Program
Emerging companies from six countries will exhibit enabling technologies at the Society of Laboratory Automation and Screening's annual European conference in Vienna this May.
News, Know-How & Standards
Disease Detection & Understanding
Gene Expression Profile Test Identifies High-Risk Melanoma Patients Missed by Traditional Methods
A combined clinicopathologic and gene expression profile test identified high-risk sentinel lymph node metastasis in T1a melanoma patients with greater specificity than standard tools.
